1Surypranate H, Maclead D. Nicorandil and cardiovascular perform- ane in patients with coronary disease [J]. J Cardiovasc Pharmacol, 2002,20 ( Suppl 3 ) :45 - 51.
2Wanqner G. Selected issues from an overview on nicorandil: toler- ance, duration of action, and long - tern) efficacy [ J ]. J CardiovascPharmacol, 2002,20 ( Suppl 3 ) : 86 - 92.
4Pr. Serge Witchitz,Jean-Yves Darmon. Nicorandil safety in the long-term treatment of coronary heart disease[J] 1995,Cardiovascular Drugs and Therapy(2):237～243
